Evidence map›Paper›PMID 32112977›Full record

ReviewInternational journal of surgery (London, England)2020

World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19).

Catrin Sohrabi, Zaid Alsafi, Niamh O'Neill, Mehdi Khan, Ahmed Kerwan, Ahmed Al-Jabir, Christos Iosifidis, Riaz Agha

Erratum issued 8 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in International journal of surgery (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 8 registered trials, which are not on this map. Cited by 2,151 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,151citing papers in PubMed, 6 pooled it
147.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04385797 unknown statusnot on this map

Cognitive Outcomes During COVID-19 confiNemeNt in Elderly and Their Caregivers Using Technologies for DEMentia

Typeobservational_patient_registrySponsorFundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludRan2020 to 2020Enrolled200ConditionsMild Cognitive Impairment, DementiaArmsTelephone interview
NCT04425720 nacompletednot on this map

Use of Remote Patient Monitoring (RPM) Platform for COVID-19 Patient

TypeinterventionalSponsorMontefiore Medical CenterRan2020 to 2021Enrolled300ConditionsCOVIDArmsLifeSignals Biosensor 1AX*, Standard of Care
NCT04443270 phase1unknown statusnot on this map

Efficacy of Chloroquine Phosphate Prophylactic Use in First-line Health Personnel Exposed to COVID-19 Patients

TypeinterventionalSponsorCMN "20 de Noviembre"Ran2020 to 2021Enrolled200ConditionsCOVID-19ArmsChloroquine phosphate
NCT04501965 phase2unknown statusnot on this map

Evaluation de l'efficacité et de la tolérance de Quinquina et d'un phytomédicament " ACAR " en Comparaison Avec l'Hydroxychloroquine Chez Des Adultes Malades de Covid-19 Sans symptômes

TypeinterventionalSponsorInstitute for Research and Development of Medicinal and Food Plants of GuineaRan2020 to 2020Enrolled231ConditionsCovid19ArmsHydroxychloroquine/Azithromycine, Quinquina-Stevia/Azythromycin, 4Plants/Azythromycin
NCT04502342 phase2unknown statusnot on this map

Évaluationefficacité et tolérance d'Une médication à Base de Cosphérunate et d'un phytomédicament Antiviral Par Voie Orale en Comparaison Avec un Traitement à Base d'Hydroxychloroquine Chez Des Adultes Malades Covid-19 Sans Complications

TypeinterventionalSponsorInstitute for Research and Development of Medicinal and Food Plants of GuineaRan2020 to 2020Enrolled30ConditionsCovid19ArmsHydroxycloroquine and Azythromycine, Cospherunate/Azythromycine, Cospherunate/Phytomedicine/Azythromycien
NCT04530617 phase2terminatednot on this map

Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients

TypeinterventionalSponsorInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranRan2020 to 2021Enrolled246ConditionsCovid19, Diabetes, Hypertension, ObesityArmsCamostat Mesilate, Artemisia Annua Leaf
NCT04668222 phase1 / phase2unknown statusnot on this mapstarted 2021, after this paper: background citation

Based on the Theory of "Body Constitution of Chinese Medicine" and "Combination of Prescription and Syndrome" to Improve COVID-19 Susceptible Body Constitution of Residents in Hong Kong

TypeinterventionalSponsorThe University of Hong KongRan2021 to 2022Enrolled480ConditionsCOVID19, Herbal MedicineArmsYu-Ping-Feng formula, Xiang-Sha-Liu-Jun formula, Liu-Wei-Di-Huang formula, Placebo for "Deficiency of Qi and Yang", Placebo for "Deficiency of Qi and Yin"
NCT04742946 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Digital Physiotherapy Practice in Long Covid-19 Patients to Improve Functional Capacity and Quality of Life.

TypeinterventionalSponsorUniversidad de GranadaRan2021 to 2022Enrolled27ConditionsLong COVID-19 SyndromeArmsDigital Physiotherapy Practice (Telerehabilitation)
3 · Its place in the literature

Who cites it

2,151 citing papers in PubMed, 6 syntheses or guidelines pooled it, 6,284 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. A Demographic Look at Cancer Treatment Behaviors during the COVID-19 Pandemic.medRxiv : the preprint server for health sciences · 2026
    Article
  20. Article

2,091 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Catrin SohrabiBarts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Zaid AlsafiUCL Medical School, University College London, United Kingdom.
Niamh O'NeillBarts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. Electronic address: niamh@ijspg.com.
Mehdi KhanUCL Medical School, University College London, United Kingdom.
Ahmed KerwanGKT School of Medical Education, King's College London, United Kingdom.
Ahmed Al-JabirGKT School of Medical Education, King's College London, United Kingdom.
Christos IosifidisBarts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Riaz AghaBarts Health NHS Trust, London, United Kingdom.
Queen Mary University of London · GBKing's College London · GBUniversity College London · GBBarts Health NHS Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An unprecedented outbreak of pneumonia of unknown aetiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus was identified as the causative agent and was subsequently termed COVID-19 by the World Health Organization (WHO). Considered a relative of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), COVID-19 is caused by a betacoronavirus named SARS-CoV-2 that affects the lower respiratory tract and manifests as pneumonia in humans. Despite rigorous global containment and quarantine efforts, the incidence of COVID-19 continues to rise, with 90,870 laboratory-confirmed cases and over 3,000 deaths worldwide. In response to this global outbreak, we summarise the current state of knowledge surrounding COVID-19.

Indexed as

BetacoronavirusCoronavirus InfectionsDisease OutbreaksGlobal HealthPandemicsPneumonia, ViralChinaCivil DefenseCoronavirusCOVID-19HumansSARS-CoV-2Severe Acute Respiratory SyndromeWorld Health OrganizationCOVID-19Global health emergencyNovel coronavirusViral transmissionWuhan

Identifiers

PMID32112977
PMCPMC7105032
OpenAlexW3010223921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 2 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.